Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective Study.

Kidney Int Rep · 2025 · PMC12034858 · PMID 40303208

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP = 0.24not close (p > 0.1)

Although our results did not reach statistical significance, it should be noted that 4.2% of DOAC patients versus 0% in the SOC group displayed TE events ( P = 0.24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.